Center for Innovative NeuroTech Advancement (CINTA) - Administrative Core
Center for Innovative NeuroTech Advancement (CINTA) - Administrative Core
批准号:
10516345
负责人:
STEVEN C. SCHACHTER
金额:
$41.33万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-30 至 2027-06-30
关键词:
AchievementAddressAreaBenchmarkingChargeClinicalCommittee MembershipCommunitiesCompanionsConflict of InterestData SecurityDiagnosisDisadvantagedElementsFeedbackFundingGleanGuidelinesHealthcareHumanInfrastructureInvestmentsLeadershipLife ExperienceModelingNeeds AssessmentNeurologyOnline SystemsPatient advocacyPatientsPoint of Care TechnologyPoliciesPrimary Health CareProcessRADx TechRecommendationResearchResourcesRoleSecureStructureTechnologyTimeTranslationsUnited States National Institutes of HealthVoiceWorkbasecareerdiversity and equityexperienceimprovedinnovationinterestnervous system disorderneurotechnologyoperationoutreachpatient orientedprogramsprototypetool development
中文摘要
摘要:行政核心
行政核心是拟议中心的核心要素,负责领导,
管理,并在指导委员会的投入下监督其他核心。CIMIT拥有广泛的
在以前的工作中建立管理核心的经验,如床旁技术研究
中心在初级保健,作为协调中心POCTRN,并作为主要建筑师的
RADx技术公司的管理结构行政核心将提供治理,制定政策,
根据指导委员会的反馈,真实的时间,
指标和基准的实现。指导委员会将成为行政核心的一部分,
负责为CINTA领导层提供战略监督和建议,以加快
商业翻译和临床影响。行政核心内的CINTA协调小组,
由PI、Co-PI和核心领导组成,将与指导委员会密切合作,
决策Schachter博士利用他在神经学,技术和病人方面的职业生涯长期兴趣
* 倡导国家领导人承诺加入指导委员会,他们反映了不同的
与NIH参与组织感兴趣的领域相对应的专业知识范围,以及相关的
生活经验和与弱势群体的工作。为了让CINTA以患者为中心,
行政核心将在行政核心内设立一个消费者咨询委员会,
病人的情况。行政核心将与外联核心合作,
在每次招标之前进行临床需求评估,以确定神经系统疾病中未满足的需求
技术解决方案将产生最大的影响。利用从
需求评估。然后,行政核心将创建、发布和传播征求意见。CINTA将
利用CIMIT在招标和子项目支持方面的丰富经验,
技术,并提供里程碑式的资金,资源和相关专业知识,以帮助创新者
将技术迅速转化为人类原型为了支持这些流程和角色,CIMIT创建了
并不断改进和利用安全的基于Web的基础设施,
有效的业务。该基础设施包括:1)CoLab平台,用于管理
招标,特别是通过多阶段,互动项目选择的应用程序流
过程,以及2)GAITS平台,帮助项目团队成功导航和加速
医疗保健创新的挑战之旅。CINTA将遵循所有适用的NIH指南,
根据NIH的保密性、利益冲突和数据安全标准。CINTA致力于嵌入
指导委员会成员所代表的多样性、公平、包容原则,
协调小组,以及病人的声音,成为行政核心的工作。
英文摘要
Abstract: ADMINISTRATIVE CORE
The Administrative Core is the central element of the proposed hub and responsible for leadership,
management, and oversight of the other Cores with input from the Steering Committee. CIMIT has extensive
experience in setting up Administrative Cores in its previous work as the Point-of-Care Technology Research
Center in Primary Care, as the Coordinating Center for POCTRN, and as the primary architect for the
administrative structure for RADx Tech. The Administrative Core will provide governance, set policy, and
continuously improve the efficiency of CINTA based on feedback from the Steering Committee, real time
metrics, and achievement of benchmarks. The Steering Committee will be part of the Administrative Core and
charged with providing CINTA leadership with strategic oversight and recommendations for accelerating
commercial translation and clinical impact. The CINTA Coordination Team within the Administrative Core,
composed of the PI, Co-PI, and Core leads, will work closely with the Steering Committee to make all major
decisions. Dr. Schachter has drawn on his career-long interests in neurology, technology, and patient
advocacy to receive commitments from national leaders to join the Steering Committee, who reflect a diverse
range of expertise corresponding to areas of interest of the NIH Participating Organizations, as well as relevant
life experiences and work with disadvantaged communities. To create a patient-centered focus for CINTA, the
Administrative Core will create a Consumer Advisory Board within the Administrative Core to convey the voice
of the patient to CINTA. The Administrative Core will work with the Outreach Core to develop and implement
clinical needs assessments in advance of each solicitation to identify unmet needs in nervous system disorders
where technology-based solutions would have the highest impact. Utilizing the information gleaned from the
needs assessments. The Administrative Core will then create, post, and disseminate a solicitation. CINTA will
leverage CIMIT’s extensive experience with solicitations and subproject support to identify the most promising
technologies and provide milestone-driven funding, resources, and relevant expertise to assist innovators in
rapidly moving technologies to human-grade prototypes. To support these processes and roles, CIMIT created
and has continuously improved and utilized, a secure, web-based infrastructure to enable efficient and
effective operations. This infrastructure consists of: 1) the CoLab platform, which is used to manage
solicitations, and specifically the flow of applications through the multi-stage, interactive project selection
process, and 2) the GAITS platform, which helps project teams successfully navigate and accelerate the
challenging journey of innovation in healthcare. CINTA will follow all applicable NIH guidelines and will abide
by NIH standards for confidentiality, conflict of interest, and data security. CINTA is committed to embedding
principles of diversity, equity, inclusion, as represented by Steering Committee membership, the CINTA
Coordination Team, as well as the voice of the patient, into the work of the Administrative Core.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Center for Innovative NeuroTech Advancement (CINTA) - Evaluation Core
-
批准号:10707297
-
项目类别:
-
资助金额:$37.84万
-
财政年份:2022
-
负责人:STEVEN C. SCHACHTER
-
依托单位:
Center for Innovative NeuroTech Advancement (CINTA) - Outreach Core
-
批准号:10707293
-
项目类别:
-
资助金额:$21.15万
-
财政年份:2022
-
负责人:STEVEN C. SCHACHTER
-
依托单位:
Center for Innovative NeuroTech Advancement (CINTA) - Administrative Core
-
批准号:10707291
-
项目类别:
-
资助金额:$245.33万
-
财政年份:2022
-
负责人:STEVEN C. SCHACHTER
-
依托单位:
Center for Innovative NeuroTech Advancement (CINTA) - Outreach Core
-
批准号:10516346
-
项目类别:
-
资助金额:$20.34万
-
财政年份:2022
-
负责人:STEVEN C. SCHACHTER
-
依托单位:
Center for Innovative NeuroTech Advancement (CINTA) - Evaluation Core
-
批准号:10516347
-
项目类别:
-
资助金额:$38.33万
-
财政年份:2022
-
负责人:STEVEN C. SCHACHTER
-
依托单位:
FEASIBILITY OF A COMBINED SEIZURE DETECTOR-VNS SYSTEM
-
批准号:7718938
-
项目类别:
-
资助金额:$0.34万
-
财政年份:2008
-
负责人:STEVEN C. SCHACHTER
-
依托单位:
EVALUATION OF ADD ON 534U87 TREATMENT OF PARTIAL SEIZURES
-
批准号:6118949
-
项目类别:
-
资助金额:$2.98万
-
财政年份:1998
-
负责人:STEVEN C. SCHACHTER
-
依托单位:
LOSIGAMONE AS MONOTHERAPY IN TREATMENT OF COMPLEX PARTIAL SEIZURES
-
批准号:6265420
-
项目类别:
-
资助金额:$2.98万
-
财政年份:1998
-
负责人:STEVEN C. SCHACHTER
-
依托单位:
TRIAL OF GP47779 (NHD OF OXCARBAZEPINE) ADMINISTERED IV TO INPATIENTS
-
批准号:6265423
-
项目类别:
-
资助金额:$2.98万
-
财政年份:1998
-
负责人:STEVEN C. SCHACHTER
-
依托单位:
EXTENSION TRIAL OF OXCARBAZEPINE IN PATIENTS W/ PARTIAL SEIZURES
-
批准号:6265424
-
项目类别:
-
资助金额:$2.98万
-
财政年份:1998
-
负责人:STEVEN C. SCHACHTER
-
依托单位:
PREGABALIN OPEN LABEL, FOLLOW ON SAFETY TRIAL IN PATIENTS W/ EPILEPSY
-
批准号:6265422
-
项目类别:
-
资助金额:$2.98万
-
财政年份:1998
-
负责人:STEVEN C. SCHACHTER
-
依托单位:
PREGABALIN IN PATIENT MONOTHERAPY TRIAL IN PATIENTS W/ EPILEPSY
-
批准号:6265421
-
项目类别:
-
资助金额:$2.98万
-
财政年份:1998
-
负责人:STEVEN C. SCHACHTER
-
依托单位:
VAGUS NERVE STIMULATION FOR ADJUNCTIVE TREATMENT OF EPILEPSY
-
批准号:6250105
-
项目类别:
-
资助金额:$1.99万
-
财政年份:1997
-
负责人:STEVEN C. SCHACHTER
-
依托单位:
LOSIGAMONE AS MONOTHERAPY FOR COMPLEX PARTIAL SEIZURES
-
批准号:2637100
-
项目类别:
-
资助金额:$3.2万
-
财政年份:1997
-
负责人:STEVEN C. SCHACHTER
-
依托单位:
TRIAL OF OXCARBAZEPINE IN PATIENTS WITH PARTIAL SEIZURES
-
批准号:6279904
-
项目类别:
-
资助金额:$2.49万
-
财政年份:1997
-
负责人:STEVEN C. SCHACHTER
-
依托单位:
EVALUATION OF ADD ON 534U87 TREATMENT OF PARTIAL SEIZURES
-
批准号:6279969
-
项目类别:
-
资助金额:$2.49万
-
财政年份:1997
-
负责人:STEVEN C. SCHACHTER
-
依托单位:
TRIAL OF OXCARBAZEPINE IN PATIENTS WITH PARTIAL SEIZURES
-
批准号:6250075
-
项目类别:
-
资助金额:$1.99万
-
财政年份:1997
-
负责人:STEVEN C. SCHACHTER
-
依托单位:
LOSIGAMONE IN TREATMENT OF COMPLEX CHILDRENS HOSPITAL
-
批准号:2741400
-
项目类别:
-
资助金额:$13.85万
-
财政年份:1997
-
负责人:STEVEN C. SCHACHTER
-
依托单位:
LOSIGAMONE IN TREATMENT OF COMPLEX CHILDRENS HOSPITAL
-
批准号:6193325
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1997
-
负责人:STEVEN C. SCHACHTER
-
依托单位:
REMACEMIDE INPATIENT SEIZURE EVALUATION TRIAL
-
批准号:6250146
-
项目类别:
-
资助金额:$1.99万
-
财政年份:1997
-
负责人:STEVEN C. SCHACHTER
-
依托单位:
海外基金